Dr. Sibo Jiang has 15+ years of experience in oligonucleotide synthesis and downstream processing. Prior to joining SanegeneBio, Dr. Jiang has held several positions with increasing responsibility at the global leading oligonucleotide CDMO Nitto Denko Avecia. Under his leadership, the oligonucleotide team had completed 70+ development and production projects, supporting programs through preclinical to clinical and pre-commercial stages. Dr. Jiang brings in extensive industrial experiences, especially in the areas of process and analytical platform establishment, method development and optimization, process validation, raw material control, and GLP/GMP scale-up production.